ALEXION PHARMACEUTICALS

World Rank (Dec-25-2022)
523
World Rank (Jan-07-2022)
523
Market Cap (Jan-07-2022)
39.000 Billion USD
World Rank (Sep-01-2021)
521
Market Cap (Sep-01-2021)
39.000 Billion USD
World Rank (Jan-01-2021)
519
Market Cap (Jan-01-2021)
34.173 Billion USD
World Rank (Jan-2020)
650
Market Cap (Jan 1st 2020)
24.023 Billion USD
Annual Revenue in USD
4,990 Million USD
Annual Net Income in USD
2,404 Million USD
Annual Results for Year Ending
Dec-2019
Headquarters Region / City
Connecticut
Headquarters Country
USA
Headquarters Sub Region
Northern America
Headquarters Continent
Americas
Company Business
Healthcare
Biotechnology
Pharmaceutical
HealthCare Products
Technology
Stock Exchange
Nasdaq
Mexico
Company Rank in Country in 2022
Company Rank in USA in 2022 is 245
Rank in Country (Jan-2021)
Company Rank in USA in 2021 is 235
Rank in Country (Jan-2020)
Rank in USA in 2020 is 275
Number of Employees
3,837
Employee Count as on Date
As on May 2021
Chairman
David R. Brennan
CEO:
Ludwig N. Hantson
Wikipedia
Company Website:
ALEXION PHARMACEUTICALS INC
IPO Year
1996
Founded Year
1992
Business Sector:
Top Technology Companies in USA
Top Healthcare Companies in USA
Top Technology Companies in S&P 500
Top Healthcare Companies in S&P 500
Top Pharmaceutical Companies in USA
Top Pharmaceutical Companies in S&P 500
About Company Business:

ALEXION PHARMACEUTICALS is USA based pharmaceutical company with headquarters in Connecticut, USA.

Astrazeneca company acquired Alexion Pharmaceuticals for 39 Billion USD in 2020.

Annual Results Summary:

ALEXION PHARMACEUTICALS - Annual Results Summary - in Million USD

Year Ending: Total Revenue Gross Profit Operating Income Net Income
Dec-2020 6,069 5,516 2,859 603
Dec-2019 4,991 4,596 2,139 2,404
Dec-2018 4,131 3,756 1,594 77.6

Share it on Social Media